Ep. 1 Frontiers: Geron, Telomeres, and China’s Rise

In the debut episode of Both Sides, we dive into the fascinating world of biotech, exploring the cutting-edge technology of telomeres with a focus on Geron Corporation and their flagship product, RYTELO™. We contrast Western and Chinese perspectives on the industry, highlighting insights from Western AI (OpenAI) and Chinese AI (DeepSeek) to analyze market potential, insider trades, and the vision of Geron’s CEO, John Scarlett. Blending tech, finance, and cultural perspectives, this episode offers a comprehensive look at a critical sector driving global innovation.